Campbell & CO Investment Adviser LLC Purchases New Stake in Chemed Corporation $CHE

Key Points

• Campbell & CO Investment Adviser LLC acquired a stake in Chemed Corporation worth approximately $5.51 million, representing 0.4% of its portfolio and making Chemed its 25th largest holding.
• Chemed recently declared a quarterly dividend of $0.60 per share, an increase from the previous dividend of $0.50, with a dividend yield of 0.5%.
• In its recent quarterly earnings report, Chemed missed earnings estimates, posting $4.27 EPS against a consensus of $6.02, while quarterly revenue was $618.8 million, below analyst expectations.

Campbell & CO Investment Adviser LLC purchased a new position in Chemed Corporation (NYSE:CHE - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 8,957 shares of the company's stock, valued at approximately $5,511,000. Chemed comprises approximately 0.4% of Campbell & CO Investment Adviser LLC's holdings, making the stock its 25th biggest position. Campbell & CO Investment Adviser LLC owned about 0.06% of Chemed as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Alpine Bank Wealth Management bought a new position in Chemed in the 1st quarter worth about $29,000. HM Payson & Co. bought a new stake in Chemed during the 1st quarter valued at $30,000. SVB Wealth LLC purchased a new stake in shares of Chemed in the 1st quarter worth $30,000. Whipplewood Advisors LLC grew its position in shares of Chemed by 54.5% during the 1st quarter. Whipplewood Advisors LLC now owns 51 shares of the company's stock worth $31,000 after buying an additional 18 shares in the last quarter. Finally, Versant Capital Management Inc increased its stake in shares of Chemed by 600.0% during the first quarter. Versant Capital Management Inc now owns 98 shares of the company's stock valued at $60,000 after buying an additional 84 shares during the period. Institutional investors own 95.85% of the company's stock.

Insider Buying and Selling at Chemed

In other news, EVP Nicholas Michael Westfall sold 10,012 shares of the company's stock in a transaction on Monday, August 4th. The shares were sold at an average price of $421.91, for a total transaction of $4,224,162.92. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director George J. Walsh III bought 200 shares of Chemed stock in a transaction dated Monday, August 4th. The stock was acquired at an average price of $417.10 per share, with a total value of $83,420.00. Following the completion of the transaction, the director directly owned 3,523 shares of the company's stock, valued at approximately $1,469,443.30. The trade was a 6.02% increase in their ownership of the stock. The disclosure for this purchase can be found here. 3.29% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

CHE has been the topic of several recent research reports. Jefferies Financial Group began coverage on shares of Chemed in a report on Friday, July 25th. They set a "hold" rating and a $500.00 target price on the stock. Royal Bank Of Canada dropped their price objective on shares of Chemed from $640.00 to $589.00 and set an "outperform" rating on the stock in a research note on Thursday, July 31st. Bank of America reduced their price objective on shares of Chemed from $708.00 to $650.00 and set a "buy" rating for the company in a research note on Monday, June 30th. Oppenheimer dropped their target price on Chemed from $650.00 to $580.00 and set an "outperform" rating on the stock in a research report on Thursday, July 31st. Finally, Wall Street Zen lowered Chemed from a "buy" rating to a "hold" rating in a research report on Saturday, July 5th. Three equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $579.75.

Chemed Stock Down 0.9%

Shares of CHE stock traded down $4.11 on Thursday, hitting $451.22. The company had a trading volume of 174,871 shares, compared to its average volume of 139,078. The firm has a market cap of $6.57 billion, a P/E ratio of 23.20, a price-to-earnings-growth ratio of 2.46 and a beta of 0.46. Chemed Corporation has a twelve month low of $408.42 and a twelve month high of $623.60. The company has a 50-day moving average price of $466.90 and a 200-day moving average price of $538.78.

Chemed (NYSE:CHE - Get Free Report) last posted its earnings results on Tuesday, July 29th. The company reported $4.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.02 by ($1.75). The firm had revenue of $618.80 million during the quarter, compared to analyst estimates of $650.60 million. Chemed had a net margin of 11.56% and a return on equity of 25.83%. The business's revenue for the quarter was up 3.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $5.47 earnings per share. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. Equities research analysts expect that Chemed Corporation will post 21.43 EPS for the current year.

Chemed Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 29th. Investors of record on Monday, August 11th will be paid a $0.60 dividend. The ex-dividend date of this dividend is Monday, August 11th. This represents a $2.40 dividend on an annualized basis and a yield of 0.5%. This is an increase from Chemed's previous quarterly dividend of $0.50. Chemed's dividend payout ratio is 12.34%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.